Drug class
Barbiturate; long-acting anticonvulsant and sedative-hypnotic
Mechanism of action
Enhances GABAA receptor-mediated inhibitory neurotransmission by prolonging the duration of chloride-channel opening, hyperpolarising neurons and reducing neuronal excitability. At higher concentrations it can also directly activate GABAA receptors.
General use cases
- Treatment of selected seizure disorders, including focal and generalised tonic-clonic seizures.
- Sedative or anaesthetic adjunct use in selected clinical settings, depending on formulation and local authorisation.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
